Join Us

We are 218,228 members in 84 forums discussing 160,960 topics.

Help with Abbreviations

Topic: Veliparib After Chemo Improves Outcomes for BRCA+ HER2- MBC

Forum: Genetic Testing —

ATM, BARD1, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, NBN, NF1, PALB2, PTEN, RAD51C, RAD51D, STK11, TP53, and mismatch repair genes (MLH1, MSH2, MSH6, PMS2, EPCAM)

Posted on: Sep 15, 2020 05:23PM

Moderators wrote:

Have you been diagnosed with metastatic HER2-negative breast cancer with a BRCA1 or BRCA2 mutation? A study found that people with this type of cancer treated with the experimental medicine veliparib and chemotherapy lived slightly longer without the cancer growing if they stayed on veliparib after stopping chemo, as long as they stopped chemo for reasons other than the cancer growing.

Read: Veliparib Maintenance After Chemo Slightly Improves Outcomes for Metastatic HER2-Negative Breast Cancer With BRCA Mutations

To send a Private Message to the Mods:
Log in to post a reply